Daly Jason B.
- SEC CIK
- 0001906486
In the past year, 1 open-market sale filing worth $3.77M and no purchases.
Current role at each company
- AMRX Amneal Pharmaceuticals, Inc.EVP, Chief Legal Officeras of Aug 13, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $3.77M
- 1 filing
- Net
- −$3.77M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Daly Jason B. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 (view filing)4:21 PM ET | Aug 11-12 | 2 days | Daly Jason B.EVP, Chief Legal Officer | SSaleClass A Common Stock | −216.6K | $17.41 | −$3.77M | −86.0%35.2K after | 2 lots |
| Aug 13, 2025 (view filing) | Aug 12 | 1 day | Daly Jason B.EVP, Chief Legal Officer | SSaleClass A Common Stock | −22.0K | $9.05 | −$199.1K | −67.5%10.6K after | |
| Mar 7, 2025 (view filing) | Mar 5-6 | 2 days | Daly Jason B.EVP, Chief Legal Officer | SSaleClass A Common Stock | −90.0K | $8.80 | −$792.2K | −73.4%32.6K after | 2 lots |
| Nov 22, 2024 (view filing) | Nov 21 | 1 day | Daly Jason B.SVP, Chief Legal Officer | SSaleClass A Common Stock | −13.7K | $8.40 | −$114.8K | −100.0%0 after | |
| Nov 19, 2024 (view filing) | Nov 15 | 4 days | Daly Jason B.SVP, Chief Legal Officer | SSaleClass A Common Stock | −43.7K | $8.61 | −$375.9K | −76.2%13.7K after |